Cleared Traditional

K872794 - MEDIX BIOTECH APOLIPOPROTEIN A-I TEST KIT

K872794 is an FDA 510(k) clearance for MEDIX BIOTECH APOLIPOPROTEIN A-I TEST KIT, manufactured by Medix Biotech, Inc.. The device is a Class 1 Immunology device with product code MSJ cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K872794 · Medix Biotech, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1987
Decision
71d
Days
Class 1
Risk

K872794 is an FDA 510(k) clearance for the MEDIX BIOTECH APOLIPOPROTEIN A-I TEST KIT. Classified as Apolipoproteins (product code MSJ), Class I - General Controls.

Submitted by Medix Biotech, Inc. (Foster City, US). The FDA issued a Cleared decision on September 23, 1987 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1475 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medix Biotech, Inc. devices

FDA 510(k) Submission Details - K872794

510(k) Number K872794 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 14, 1987
Decision Date September 23, 1987
Days to Decision 71 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 105d · This submission: 71d
Pathway characteristics
Predicate-based equivalence.

MSJ Device Classification - Class 1, General Controls

Product Code MSJ Apolipoproteins
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1475
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - MSJ Apolipoproteins

All 36
Devices cleared under the same product code (MSJ) and FDA review panel - the closest regulatory comparables to K872794.
MODIFIED SPQ(TM) TEST SYSTEM FOR APOLIPOPROTEIN B
K881898 · Atlantic Antibodies · Jun 1988
APOLIPOPROTEIN A1
K873863 · Unipath , Ltd. · Oct 1987
APOLIPOPROTEIN B
K873864 · Unipath , Ltd. · Oct 1987
RAICHEM(TM) SPIA(TM) APO A-1 REAGENTS
K872079 · Reagents Applications, Inc. · Jun 1987
SPQ(TM) TEST SYSTEM FOR APOLIPOPROTEIN B
K870564 · Atlantic Antibodies · Mar 1987
SPQ(TM) TEST SYSTEM FOR APOLIPOPROTEIN AL
K870862 · Atlantic Antibodies · Mar 1987